Brief: Cadrenal Therapeutics Provides Q1 Corporate Update
May 10 (Reuters) - Cadrenal Therapeutics Inc CVKD.O :
* CADRENAL THERAPEUTICS PROVIDES FIRST QUARTER 2023
CORPORATE
UPDATE
* CADRENAL THERAPEUTICS INC - AS OF MARCH 31, 2023, CASH
BALANCES
WERE $4.0 MILLION
* CADRENAL THERAPEUTICS INC - BELIEVES IT HAS SUFFICIENT
CAPITAL
TO FUND OPERATIONS THROUGH Q2 2024
Source text for Eikon: ID:nPn9Gq2WNa
Further company coverage: CVKD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cadrenal Therapeutics
See all newsCadrenal Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Cadrenal Therapeutics Q2 net loss narrows as operating expenses fall
Cadrenal Therapeutics Inc expected to post a loss of $1.42 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Salesforce
U.S. STOCKS ON THE MOVE-SpaceX, Sandisk, Marvell Technology